Arizona State Retirement System’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,892
Closed -$180K 2290
2022
Q3
$180K Buy
11,892
+89
+0.8% +$1.03K ﹤0.01% 1927
2022
Q2
$89K Sell
11,803
-358
-3% -$2.52K ﹤0.01% 2139
2022
Q1
$111K Buy
12,161
+84
+0.7% +$647 ﹤0.01% 2142
2021
Q4
$85K Sell
12,077
-58
-0.5% -$607 ﹤0.01% 2235
2021
Q3
$138K Buy
12,135
+46
+0.4% +$672 ﹤0.01% 2142
2021
Q2
$194K Buy
12,089
+505
+4% +$8.66K ﹤0.01% 2129
2021
Q1
$207K Buy
11,584
+116
+1% +$2K ﹤0.01% 2027
2020
Q4
$155K Sell
11,468
-450
-4% -$5.44K ﹤0.01% 2016
2020
Q3
$140K Buy
+11,918
New +$145K ﹤0.01% 1880
2020
Q2
Sell
-10,331
Closed -$139K 1912
2020
Q1
$139K Buy
+10,331
New +$196K ﹤0.01% 1587

Arizona State Retirement System's AERI Position: Q4 2022 in Review

Arizona State Retirement System sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 11,892 shares — an estimated $180K sold.

Arizona State Retirement System first reported a position in AERI in Q1 2020 and held it in 10 quarters. The position peaked at $207K in Q1 2021. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Arizona State Retirement System reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Arizona State Retirement System sold 11,892 Aerie Pharmaceuticals shares in Q4 2022, an estimated $180K.
  • Arizona State Retirement System first reported a position in Aerie Pharmaceuticals in Q1 2020 and held it in 10 quarters.
  • Arizona State Retirement System's Aerie Pharmaceuticals position peaked at $207K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Arizona State Retirement System's 13F filing for Q4 2022, filed 8 Feb 2023.